|
T25268 |
Coblopasvir
|
|
Others
|
|
Coblopasvir is a pan-genotypic non-structural protein 5A (NS5A) inhibitor. It can be used to study chronic hepatitis C virus infection. |
|
T25268L |
Coblopasvir dihydrochloride
|
Coblopasvir dihydrochloride(1312608-46-0 Free base) |
HCV Protease
|
|
Coblopasvir dihydrochloride can be used to study chronic HCV infection and is a pan-genotypic nonstructural protein 5A (NS5A) inhibitor. |
|
T4544 |
Elbasvir
|
MK-8742 |
HCV Protease
|
|
Elbasvir (MK-8742) is an inhibitor of nonstructural protein 5A (NS5A) of hepatitis C virus (HCV) being developed as a component of treatment regimens for chronic HCV infection. |
|
T68466 |
BI-207524
|
|
|
|
BI-207524 is a novel NS5B Thumb Pocket 1 Inhibitor with Improved Potency for the Potential Treatment of Chronic Hepatitis C Virus Infection. |
|
T74588 |
Yimitasvir diphosphate
|
|
|
|
Yimitasvir (Emitasvir) diphosphate is an orally administered inhibitor of the hepatitis C virus (HCV) nonstructural protein 5A (NS5A), utilized in the research of chronic hepatitis C virus infection [1]. |
|
T78716 |
MKA031
|
|
|
|
MKA031 (compound 6y) is a non-competitive inhibitor of macrophage migration inhibitory factor (MIF), exhibiting an IC50 of 1.7 μM. It disrupts the MIF-aryl hydrocarbon receptor interacting protein (AIF) interaction, impe... |
